The US Food and Drug Administration (FDA) approved Jelmyto (mitomycin gel) for a type of urothelial cancer, which is a cancer of the lining of the urinary system.
Taking certain supplements while undergoing chemotherapy for breast cancer may do more harm than good. A small study found that patients who took antioxidants had higher chances of cancer recurrence and death.
Research presented at the San Antonio Breast Cancer Symposium may result in a new standard of care for some people with HER2 positive, early stage breast cancer.
A federally funded study has found that many women with the most common type of early stage breast cancer likely do not need chemotherapy after surgery.